ODAC Review Of Schering-Plough’s PegIntron For Melanoma Postponed
This article was originally published in The Pink Sheet Daily
Executive Summary
Expected review of firm’s supplemental BLA for adjuvant treatment of melanoma postponed as FDA requests additional data.